All Phenotypes Aifm1<tm2Pngr> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Aifm1^tm2Pngr/Y Foxg1^tm1(cre)Skm/Foxg1⁺	involves: 129P2/OlaHsd	MGI:3687280
cn2	Apaf1^{Gt(IRESBetageo)XIX18Pgr}/Apaf1^{Gt(IRESBetageo)XIX18Pgr} Aifm1^tm2Pngr/Y Foxg1^tm1(cre)Skm/Foxg1⁺	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	MGI:3687281
cn3	Aifm1^tm2Pngr/Y Tg(Ckmm-cre)5Khn/0	involves: 129P2/OlaHsd * FVB	MGI:3687267
cn4	Aifm1^tm2Pngr/Y Tmem163^{Tg(ACTB-cre)2Mrt}/0	involves: 129P2/OlaHsd * FVB/N	MGI:3687265
cn5	Aifm1^tm2Pngr/Aifm1⁺ Tmem163^{Tg(ACTB-cre)2Mrt}/0	involves: 129P2/OlaHsd * FVB/N	MGI:3687266

Allelic Composition	Aifm1^tm2Pngr/Y Foxg1^tm1(cre)Skm/Foxg1⁺
Genetic Background	involves: 129P2/OlaHsd

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aifm1^tm2Pngr mutation (0 available); any Aifm1 mutation (10 available)
Foxg1^tm1(cre)Skm mutation (2 available); any Foxg1 mutation (29 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

lethality throughout fetal growth and development, incomplete penetrance ( J:112874 )

• conditional mutants (males) die by E17

cellular

abnormal mitochondrial morphology ( J:112874 )

• mitochondria in cultured neurites are short and fragmented

• while morphology is restored by expression of anchored Pdcd8, mitochondrial length is increased compared to controls; cristae in mutant neurons are dilated and disorganized vs wild-type; cross-sectional distance of mitochondrial cristae is ~2.5-fold wider than wild-type; expression of anchored Pdcd8 reduces intercristae distance from 20 to 17 microns

decreased neuron apoptosis ( J:112874 )

• cultured neurons transfected with a mitochondrially-anchored Pdcd8 show similar survival to wild-type neurons expressing GFP

• after camptothecin treatment, neurons show increased survival vs wild-type over the first 12 hours (~45% loss vs ~55% in wild-type)

increased neuron apoptosis ( J:112874 )

• there is a marked increase in cell death in postmitotic cell regions

abnormal mitochondrial physiology ( J:112874 )

• membrane potential is hyperpolarized relative to wild-type cells

• membrane potential hyperpolarization is restored to normal by expression of anchored Pdcd8

• ATP production and oxygen consumption in cultured mutant neurons is restored by mitochondrially anchored Pdcd8

decreased mitochondrial fission ( J:112874 )

• mutant neurites have few mitochondria vs wild-type

homeostasis/metabolism

abnormal enzyme/coenzyme level ( J:112874 )

• expression of complex I respiratory chain complex is abrogated in mutants

nervous system

decreased neuron apoptosis ( J:112874 )

• cultured neurons transfected with a mitochondrially-anchored Pdcd8 show similar survival to wild-type neurons expressing GFP

• after camptothecin treatment, neurons show increased survival vs wild-type over the first 12 hours (~45% loss vs ~55% in wild-type)

increased neuron apoptosis ( J:112874 )

• there is a marked increase in cell death in postmitotic cell regions

thin cerebral cortex ( J:112874 )

• cortical thickness is reduced, mostly at the cortical plate (CP) and intermediate zone (IZ) and to lesser extent the subventricular zone (SVZ)

Allelic Composition	Apaf1^{Gt(IRESBetageo)XIX18Pgr}/Apaf1^{Gt(IRESBetageo)XIX18Pgr} Aifm1^tm2Pngr/Y Foxg1^tm1(cre)Skm/Foxg1⁺
Genetic Background	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aifm1^tm2Pngr mutation (0 available); any Aifm1 mutation (10 available)
Apaf1^{Gt(IRESBetageo)XIX18Pgr} mutation (1 available); any Apaf1 mutation (78 available)
Foxg1^tm1(cre)Skm mutation (2 available); any Foxg1 mutation (29 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cellular

decreased neuron apoptosis ( J:112874 )

• neurons show increased survival vs wild-type after camptothecin treatment

• neurons cultured in pyruvate supplemented media show increased survival after camptothecin treatment

• expression of anchored Pdcd8 does not provide further protection from death to neurons

increased neuron apoptosis ( J:112874 )

• cultured neurons show increased apoptosis reconstituted with wild-type Pdcd8 compared to control; mutant neurons expressing Pdcd8 with a nuclear exclusion sequence show cell death equivalent to control neurons expressing GFP

abnormal mitochondrial physiology ( J:112874 )

• cultured neurons can maintain oxygen consumption after camptothecin treatment if anchored Pdcd8 is expressed

nervous system

decreased neuron apoptosis ( J:112874 )

• neurons show increased survival vs wild-type after camptothecin treatment

• neurons cultured in pyruvate supplemented media show increased survival after camptothecin treatment

• expression of anchored Pdcd8 does not provide further protection from death to neurons

increased neuron apoptosis ( J:112874 )

thickened cerebral cortex ( J:112874 )

• cortex is thickened compared to Pdcd8 conditional embryos

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

growth/size/body

enlarged heart ( J:113016 )

• mice have grossly enlarged hearts at 9 weeks of age

cardiac hypertrophy ( J:113016 )

• 9-week old mice show significant increase in heart weight/tibial-length ratios

weight loss ( J:113016 )

• male mutants appear normal at 2 months; at 3 months, they display significant weight loss

cellular

abnormal mitochondrial morphology ( J:113016 )

• mitochondria display abnormal morphology at 9 weeks but not at 4 weeks of age

abnormal mitochondrial crista morphology ( J:113016 )

• mitochondria display marked cristolysis at 9 weeks but not at 4 weeks of age

increased mitochondrial number ( J:113016 )

• heart muscle has increased number of mitochondria

abnormal aerobic respiration ( J:113016 )

• lipid peroxidation markers are increased >2.5 fold in 9-week old mutants indicating impaired mitochondrial respiration

abnormal mitochondrial physiology ( J:113016 )

• a significant increase in lactate/pyruvate ratio is observed

abnormal respiratory electron transport chain ( J:113016 )

• complex I respiratory chain complex is reduced to ~50% of control levels in heart and gastrocnemius at 5 weeks of age, while complex III level is ~90% of control in heart and gastrocnemius

abnormal mitochondrial ATP synthesis coupled electron transport ( J:113016 )

• respiratory chain enzyme activities in soleus, gastrocnemium and heart muscle is severely reduced; complex I activity in skeletal muscle and heart is reduced (up to 80%) while complex IV activity in the heart is more mildly reduced at 18 weeks of age

oxidative stress ( J:113016 )

• lipid peroxidation markers (indicators or oxidative stress) are increased >2.5 fold in 9-week old mutants

cardiovascular system

abnormal myocardial fiber morphology ( J:113016 )

• heart muscle shows pronounced myofibrillar fragmentation and disorganization and increased number of mitochondria

increased myocardial fiber size ( J:113016 )

• individual cardiomyocytes are markedly increased in size

enlarged heart ( J:113016 )

• mice have grossly enlarged hearts at 9 weeks of age

cardiac hypertrophy ( J:113016 )

• 9-week old mice show significant increase in heart weight/tibial-length ratios

dilated cardiomyopathy ( J:113016 )

• mutants display severe dilated cardiomyopathy

decreased cardiac muscle contractility ( J:113016 )

• detectable by 4 weeks of age and progressively worsens

• significant decrease is shown by decreased percentage fractional shortening, decreased velocity of circumferential fiber shortening and reduced peak aortic outlflow velocity

• also, dP/dT_max and dP/dT_min are reduced significantly

abnormal heart ventricle pressure ( J:113016 )

• mutants have significant decrease in ventricular blood pressures

muscle

abnormal myocardial fiber morphology ( J:113016 )

• heart muscle shows pronounced myofibrillar fragmentation and disorganization and increased number of mitochondria

increased myocardial fiber size ( J:113016 )

• individual cardiomyocytes are markedly increased in size

dilated cardiomyopathy ( J:113016 )

• mutants display severe dilated cardiomyopathy

decreased cardiac muscle contractility ( J:113016 )

• detectable by 4 weeks of age and progressively worsens

• significant decrease is shown by decreased percentage fractional shortening, decreased velocity of circumferential fiber shortening and reduced peak aortic outlflow velocity

• also, dP/dT_max and dP/dT_min are reduced significantly

abnormal skeletal muscle fiber morphology ( J:113016 )

• myofibers from 3-month old mice display irregular contours

increased skeletal muscle fiber diameter ( J:113016 )

• myofiber cross-sectional area is reduced 2-fold in triceps of 3 month old mice vs littermate controls

decreased skeletal muscle mass ( J:113016 )

• male hemizygotes display significant loss of muscle mass at 3 months, becoming detectable at 10 weeks of age compared to littermate controls (Pdcd8-sufficent and non-transgenic hemizygotes)

muscle degeneration ( J:113016 )

• muscle degeneration is progressive, becoming detectable at 10 weeks of age; it is most apparent in fast-twitch muscles (gastrocnemium, triceps, quadriceps)

muscular atrophy ( J:113016 )

• all skeletal muscles analyzed including triceps, pectoralis, quadriceps, gluteus, and gastrocnemius muscles are significantly atrophied male hemizygotes

homeostasis/metabolism

increased circulating lactate level ( J:113016 )

• plasma lactate levels increase progressively with muscle loss

• a significant increase in lactate/pyruvate ratio is observed

abnormal glucose homeostasis ( J:113016 )

• mutant cardiomyocytes undergo compensatory metabolic switch toward glycolysis, and away from pyruvate utilization as result of impaired mitochondrial respiration

abnormal hormone level ( J:113016 )

• mutants show significant upregulation of atrial naturietic factor (ANF) and b-type natruietic peptide (BNP)

decreased catalase activity ( J:113016 )

• at 4.5 months of age, heart and skeletal muscle show significant reductions in catalase activity

behavior/neurological

lethargy ( J:113016 )

• loss of muscle mass results makes mice extremely lethargic by 5 months of age

Allelic Composition	Aifm1^tm2Pngr/Y Tmem163^{Tg(ACTB-cre)2Mrt}/0
Genetic Background	involves: 129P2/OlaHsd * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aifm1^tm2Pngr mutation (0 available); any Aifm1 mutation (10 available)
Tmem163^{Tg(ACTB-cre)2Mrt} mutation (3 available); any Tmem163 mutation (35 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:113016 )

• male mutants are present at Mendelian ratios at E7.5 and 10.5, but no viable embryos are recovered after E12.5

embryo

embryonic growth retardation ( J:113016 )

• embryos between E7.5 and 10.5 exhibit severe growth retardation

growth/size/body

embryonic growth retardation ( J:113016 )

• embryos between E7.5 and 10.5 exhibit severe growth retardation

Allelic Composition	Aifm1^tm2Pngr/Aifm1⁺ Tmem163^{Tg(ACTB-cre)2Mrt}/0
Genetic Background	involves: 129P2/OlaHsd * FVB/N

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

prenatal lethality, incomplete penetrance ( J:113016 )

• a percentage of female heterozygotes die during development; female mutants are born at a lower than expected frequency

growth/size/body

decreased body size ( J:113016 )

• females surviving through birth are smaller in size than wild-type littermates but appear healthy and fertile

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 07/02/2024 MGI 6.13